Safety and Efficacy Study of Kaname Coronary Stent System for the Treatment of Patients With Coronary Artery Disease (KARE)
Clinical Evaluation of Kaname Cobalt-Chromium Coronary Stent System in the Treatment of Patients With Coronary Artery Disease
Sponsor: Terumo Europe N.V.
A NA clinical study on Angioplasty, Transluminal, Percutaneous Coronary and Coronary Artery Disease, this trial is completed. The trial is conducted by Terumo Europe N.V. and has accumulated 8 data snapshots since 2009. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Nov 2019 — Jan 2021 [monthly]
Completed NA
Status: Unknown Status → Completed · Phase: PHASE2_PHASE3 → NA
▶ Show 3 earlier versions
-
Jun 2018 — Nov 2019 [monthly]
Unknown Status PHASE2_PHASE3
-
Oct 2017 — Jun 2018 [monthly]
Unknown Status PHASE2_PHASE3
Status: Active Not Recruiting → Unknown Status
-
Jan 2017 — Oct 2017 [monthly]
Active Not Recruiting PHASE2_PHASE3
First recorded
Oct 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Terumo Europe N.V.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Belgrade, Serbia , Florence, Italy , Fulda, Germany , Ludwigshafen, Germany , Lyon, France , Madrid, Spain , Mainz, Germany , Milan, Italy , Nantes, France , Nîmes, France and 4 more locations